Publications by authors named "Larry Bauer"

Claim this Profile
U
Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
Jasmanda Wu, Cunlin Wang, Sengwee Toh, Federica Edith Pisa, Larry Bauer

Pharmacoepidemiol Drug Saf· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical issues related to clinical research and rare diseases: 15th Gordon L. Snider Critical Issues Workshop, April 1, 2016, Bethesda, Maryland.
Marilyn Coors, Larry Bauer, Kelly Edwards, Karen Erickson, Aaron Goldenberg

Transl Sci Rare Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
Christopher M Traudt, Ronald J McPherson, Larry A Bauer, Todd L Richards, Thomas M Burbacher

Dev Neurosci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
Yvonne W Wu, Larry A Bauer, Roberta A Ballard, Donna M Ferriero, David V Glidden

Pediatrics· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010.
Anne R Pariser, Daniel J Slack, Larry J Bauer, Catherine A Warner, LaRee A Tracy

Drug Discov Today· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
Sandra E Juul, Ronald J McPherson, Larry A Bauer, Kelly J Ledbetter, Christine A Gleason

Pediatrics· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats.
Pamela A Statler, Ronald J McPherson, Larry A Bauer, Brian A Kellert, Sandra E Juul

Pediatr Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creatinine clearance versus glomerular filtration rate for the use of renal drug dosing in patients with kidney dysfunction.
Larry Bauer

Pharmacotherapy· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.
Larry A Bauer, Douglas J Black, Jennifer S Lill, Julie Garrison, Vidmantas A Raisys

Antimicrob Agents Chemother· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulations of Levothyroxine Bioavailability Using a Single-Dose Study Protocol.
Larry A. Bauer

Am J Ther· June 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis